Literature DB >> 23360155

Host defense at the ocular surface.

Eric Pearlman1, Yan Sun, Sanhita Roy, Mausita Karmakar, Amy G Hise, Loretta Szczotka-Flynn, Mahmoud Ghannoum, Holly R Chinnery, Paul G McMenamin, Arne Rietsch.   

Abstract

Microbial infections of the cornea frequently cause painful, blinding and debilitating disease that is often difficult to treat and may require corneal transplantation. In addition, sterile corneal infiltrates that are associated with contact lens wear cause pain, visual impairment and photophobia. In this article, we review the role of Toll-Like Receptors (TLR) in bacterial keratitis and sterile corneal infiltrates, and describe the role of MD-2 regulation in LPS responsiveness by corneal epithelial cells. We conclude that both live bacteria and bacterial products activate Toll-Like Receptors in the cornea, which leads to chemokine production and neutrophil recruitment to the corneal stroma. While neutrophils are essential for bacterial killing, they also cause tissue damage that results in loss of corneal clarity. These disparate outcomes, therefore, represent a spectrum of disease severity based on this pathway, and further indicate that targeting the TLR pathway is a feasible approach to treating inflammation caused by live bacteria and microbial products. Further, as the P. aeruginosa type III secretion system (T3SS) also plays a critical role in disease pathogenesis by inducing neutrophil apoptosis and facilitating bacterial growth in the cornea, T3SS exotoxins are additional targets for therapy for P. aeruginosa keratitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360155      PMCID: PMC3750950          DOI: 10.3109/08830185.2012.749400

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  113 in total

1.  Vasoactive intestinal peptide downregulates proinflammatory TLRs while upregulating anti-inflammatory TLRs in the infected cornea.

Authors:  Xiaoyu Jiang; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Role of Pseudomonas aeruginosa type III effectors in disease.

Authors:  Joanne Engel; Priya Balachandran
Journal:  Curr Opin Microbiol       Date:  2009-01-23       Impact factor: 7.934

3.  A protective role for IL-6 in staphylococcal microbial keratitis.

Authors:  Emma B H Hume; Nerida Cole; Linda L Garthwaite; Shamila Khan; Mark D P Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

4.  VIP and growth factors in the infected cornea.

Authors:  Xiaoyu Jiang; Sharon A McClellan; Ronald P Barrett; Elizabeth A Berger; Yunfan Zhang; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

5.  Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000.

Authors:  Brigitte A Cowell; Barry A Weissman; Karen K Yeung; Larisa Johnson; Sharon Ho; Rajana Van; David Bruckner; Bartly Mondino; Suzanne M J Fleiszig
Journal:  Cornea       Date:  2003-03       Impact factor: 2.651

6.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis.

Authors:  Sixto M Leal; Susan Cowden; Yen-Cheng Hsia; Mahmoud A Ghannoum; Michelle Momany; Eric Pearlman
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  Development of a Streptococcus pneumoniae keratitis model in mice.

Authors:  Quincy C Moore; Clare C McCormick; Erin W Norcross; Chinwendu Onwubiko; Melissa E Sanders; Jonathan Fratkin; Larry S McDaniel; Richard J O'Callaghan; Mary E Marquart
Journal:  Ophthalmic Res       Date:  2009-07-23       Impact factor: 2.892

9.  Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin.

Authors:  Jing Zhang; Keping Xu; Balamurali Ambati; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

10.  Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions.

Authors:  Loretta B Szczotka-Flynn; Yoshifumi Imamura; Jyotsna Chandra; Changping Yu; Pranab K Mukherjee; Eric Pearlman; Mahmoud A Ghannoum
Journal:  Cornea       Date:  2009-09       Impact factor: 2.651

View more
  43 in total

1.  Acidosis potentiates the host proinflammatory interleukin-1β response to Pseudomonas aeruginosa infection.

Authors:  Iviana M Torres; Yash R Patankar; Tamer B Shabaneh; Emily Dolben; Deborah A Hogan; David A Leib; Brent L Berwin
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.

Authors:  Aaron B Sullivan; K P Connie Tam; Matteo M E Metruccio; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

3.  A novel murine model for contact lens wear reveals clandestine IL-1R dependent corneal parainflammation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa.

Authors:  Matteo M E Metruccio; Stephanie J Wan; Hart Horneman; Abby R Kroken; Aaron B Sullivan; Tan N Truong; James J Mun; Connie K P Tam; Robin Frith; Laurence Welsh; Melanie D George; Carol A Morris; David J Evans; Suzanne M J Fleiszig
Journal:  Ocul Surf       Date:  2018-11-12       Impact factor: 5.033

Review 4.  Peptide therapeutics for treating ocular surface infections.

Authors:  Curtis R Brandt
Journal:  J Ocul Pharmacol Ther       Date:  2014-09-24       Impact factor: 2.671

Review 5.  Inflammasomes, the eye and anti-inflammasome therapy.

Authors:  P Yerramothu; A K Vijay; M D P Willcox
Journal:  Eye (Lond)       Date:  2017-11-24       Impact factor: 3.775

6.  Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6.

Authors:  Antonella Cano; Antonella Mattana; Stuart Woods; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

Review 7.  Host immune cellular reactions in corneal neovascularization.

Authors:  Nizar S Abdelfattah; Mohamed Amgad; Amira A Zayed
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

8.  Inhibition of Corneal Inflammation by the Resolvin E1.

Authors:  Ji-Eun Lee; Yan Sun; Per Gjorstrup; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

9.  The role of toll-like receptor 4 in corneal epithelial wound healing.

Authors:  Medi Eslani; Asadolah Movahedan; Neda Afsharkhamseh; Herve Sroussi; Ali R Djalilian
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

Review 10.  Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?

Authors:  Katie Bryant-Hudson; Christopher D Conrady; Daniel J J Carr
Journal:  Prog Retin Eye Res       Date:  2013-07-19       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.